A lawsuit was filed on behalf of investors in Deutsche Bank Aktiengesellschaft (NYSE: DB) shares over alleged securities laws violations.
San Diego, CA -- (SBWIRE) -- 06/19/2018 -- An investor, who purchased shares of Deutsche Bank Aktiengesellschaft (NYSE: DB), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Deutsche Bank Aktiengesellschaft in connection with certain allegedly false and misleading statements.
Investors, who purchased shares of Deutsche Bank Aktiengesellschaft (NYSE: DB), have certain options and for certain investors are short and strict deadlines running. Deadline: August 6, 2018. NYSE: DB investors should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
According to the complaint the plaintiff alleges on behalf of purchasers of Deutsche Bank Aktiengesellschaft (NYSE: DB) common shares between March 20, 2017 and May 30, 2018, that the defendants violated Federal Securities Laws.
More specifically, the plaintiff claims that between March 20, 2017 and May 30, 2018, the defendants made false and/or misleading statements and/or failed to disclose that Deutsche Bank's internal control environment and infrastructure were materially weak and deficient, and that as a result, Deutsche Bank's statements about the Company's business and operations were materially false and misleading at all relevant times.
On May 31, 2018, it was reported that the U.S. Federal Reserve has designated Deutsche Bank's U.S. business to be in "troubled condition," citing concerns "about its controls around measuring financial exposure to clients and valuing collateral that backed loans." The article further reported that the Federal Deposit Insurance Corporation has added Deutsche Bank's subsidiary Deutsche Bank Trust Company Americas to its "problem banks" list of at-risk institutions.
Those who purchased shares of Deutsche Bank Aktiengesellschaft (NYSE: DB) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels